{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:12:22Z","timestamp":1795093942999,"version":"4.10.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Todd and Karen Wanek Family Program for HLHS at Mayo Clinic","award":["The Todd and Karen Wanek Family Program for HLHS at Mayo Clinic"],"award-info":[{"award-number":["The Todd and Karen Wanek Family Program for HLHS at Mayo Clinic"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04316-3","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:41:34Z","timestamp":1746092494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3937-9102","authenticated-orcid":false,"given":"Carlos","family":"Gallego-Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Jaggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold M.","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar F.","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Yasir","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Rossano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton E.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew K.","family":"Seisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Cantero","family":"Peral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"4316_CR1","doi-asserted-by":"publisher","unstructured":"van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJM et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol [Internet]. 2011;58(21):2241\u20137. Available from: https:\/\/doi.org\/10.1016\/j.jacc.2011.08.025","DOI":"10.1016\/j.jacc.2011.08.025"},{"key":"4316_CR2","doi-asserted-by":"publisher","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation [Internet]. 2021;143(8):e254\u2013743. Available from: https:\/\/doi.org\/10.1161\/CIR.0000000000000950","DOI":"10.1161\/CIR.0000000000000950"},{"key":"4316_CR3","doi-asserted-by":"publisher","unstructured":"De Rita F, Crossland D, Griselli M, Hasan A. Management of the failing Fontan. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu [Internet]. 2015;18(1):2\u20136. Available from: https:\/\/doi.org\/10.1053\/j.pcsu.2015.01.004","DOI":"10.1053\/j.pcsu.2015.01.004"},{"key":"4316_CR4","doi-asserted-by":"publisher","unstructured":"Gordon BM, Rodriguez S, Lee M, Chang R-K. Decreasing number of deaths of infants with hypoplastic left heart syndrome. J Pediatr [Internet]. 2008;153(3):354\u20138. Available from: https:\/\/doi.org\/10.1016\/j.jpeds.2008.03.009","DOI":"10.1016\/j.jpeds.2008.03.009"},{"key":"4316_CR5","doi-asserted-by":"publisher","unstructured":"Barron DJ, Kilby MD, Davies B, Wright JGC, Jones TJ, Brawn WJ. Hypoplastic left heart syndrome. Lancet [Internet]. 2009;374(9689):551\u201364. Available from: https:\/\/doi.org\/10.1016\/S0140-6736(09)60563-8","DOI":"10.1016\/S0140-6736(09)60563-8"},{"key":"4316_CR6","doi-asserted-by":"publisher","unstructured":"Sano S, Ishino K, Kawada M, Arai S, Kasahara S, Asai T et al. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg [Internet]. 2003;126(2):504\u20139; discussion 509\u2013\u200910. Available from: https:\/\/doi.org\/10.1016\/s0022-5223(02)73575-7","DOI":"10.1016\/s0022-5223(02)73575-7"},{"key":"4316_CR7","doi-asserted-by":"publisher","unstructured":"Ohye RG, Schranz D, D\u2019Udekem Y. Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions. Circulation [Internet]. 2016;134(17):1265\u201379. Available from: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022816","DOI":"10.1161\/CIRCULATIONAHA.116.022816"},{"key":"4316_CR8","doi-asserted-by":"publisher","unstructured":"Metcalf MK, Rychik J. Outcomes in Hypoplastic Left Heart Syndrome. Pediatr Clin North Am [Internet]. 2020;67(5):945\u201362. Available from: https:\/\/doi.org\/10.1016\/j.pcl.2020.06.008","DOI":"10.1016\/j.pcl.2020.06.008"},{"key":"4316_CR9","doi-asserted-by":"publisher","unstructured":"Rychik J, Goldberg DJ. Late consequences of the Fontan operation. Circulation [Internet]. 2014;130(17):1525\u20138. Available from: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.005341","DOI":"10.1161\/CIRCULATIONAHA.114.005341"},{"key":"4316_CR10","doi-asserted-by":"publisher","unstructured":"Gewillig M, Brown SC, van de Bruaene A, Rychik J. Providing a framework of principles for conceptualising the Fontan circulation. Acta Paediatr [Internet]. 2020;109(4):651\u20138. Available from: https:\/\/doi.org\/10.1111\/apa.15098","DOI":"10.1111\/apa.15098"},{"key":"4316_CR11","doi-asserted-by":"publisher","unstructured":"Bittle GJ, Morales D, Deatrick KB, Parchment N, Saha P, Mishra R et al. Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions. Circ Res [Internet]. 2018;123(2):288\u2013300. Available from: https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311206","DOI":"10.1161\/CIRCRESAHA.117.311206"},{"key":"4316_CR12","doi-asserted-by":"publisher","unstructured":"Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M et al. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res [Internet]. 2015;116(4):653\u201364. Available from: https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304671","DOI":"10.1161\/CIRCRESAHA.116.304671"},{"key":"4316_CR13","doi-asserted-by":"crossref","unstructured":"Kaushal S, Wehman B, Pietris N, Naughton C, Bentzen SM, Bigham G et al. Study design and rationale for ELPIS: A phase I\/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome. Am Heart J [Internet]. 2017;192:48\u201356. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0002870317301825","DOI":"10.1016\/j.ahj.2017.06.009"},{"key":"4316_CR14","doi-asserted-by":"publisher","unstructured":"de Jong R, Houtgraaf JH, Samiei S, Boersma E, Duckers HJ. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv [Internet]. 2014;7(2):156\u201367. Available from: https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.113.001009","DOI":"10.1161\/CIRCINTERVENTIONS.113.001009"},{"key":"4316_CR15","doi-asserted-by":"publisher","unstructured":"Delewi R, Hirsch A, Tijssen JG, Sch\u00e4chinger V, Wojakowski W, Roncalli J et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J [Internet]. 2014;35(15):989\u201398. Available from: https:\/\/doi.org\/10.1093\/eurheartj\/eht372","DOI":"10.1093\/eurheartj\/eht372"},{"key":"4316_CR16","doi-asserted-by":"publisher","unstructured":"Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S et al. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail [Internet]. 2012;14(1):91\u2013105. Available from: https:\/\/doi.org\/10.1093\/eurjhf\/hfr148","DOI":"10.1093\/eurjhf\/hfr148"},{"key":"4316_CR17","doi-asserted-by":"publisher","unstructured":"Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet [Internet]. 2012;379(9819):895\u2013904. Available from: https:\/\/doi.org\/10.1016\/S0140-6736(12)60195-0","DOI":"10.1016\/S0140-6736(12)60195-0"},{"key":"4316_CR18","doi-asserted-by":"publisher","unstructured":"Burkhart HM, Qureshi MY, Rossano JW, Cantero Peral S, O\u2019Leary PW, Hathcock M et al. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections. J Thorac Cardiovasc Surg [Internet]. 2019;158(6):1614\u201323. Available from: https:\/\/doi.org\/10.1016\/j.jtcvs.2019.06.001","DOI":"10.1016\/j.jtcvs.2019.06.001"},{"key":"4316_CR19","doi-asserted-by":"publisher","unstructured":"Vincenti M, O\u2019Leary PW, Qureshi MY, Seisler DK, Burkhart HM, Cetta F et al. Clinical Impact of Autologous Cell Therapy on Hypoplastic Left Heart Syndrome After Bidirectional Cavopulmonary Anastomosis. Semin Thorac Cardiovasc Surg [Internet]. 2021 Autumn;33(3):791\u2013801. Available from: https:\/\/doi.org\/10.1053\/j.semtcvs.2020.11.002","DOI":"10.1053\/j.semtcvs.2020.11.002"},{"key":"4316_CR20","doi-asserted-by":"publisher","unstructured":"Ishigami S, Ohtsuki S, Eitoku T, Ousaka D, Kondo M, Kurita Y et al. Intracoronary Cardiac Progenitor Cells in Single Ventricle Physiology: The PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) Randomized Phase 2 Trial. Circ Res [Internet]. 2017;120(7):1162\u201373. Available from: https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.310253","DOI":"10.1161\/CIRCRESAHA.116.310253"},{"key":"4316_CR21","doi-asserted-by":"publisher","unstructured":"Santos Nascimento D, Mosqueira D, Sousa LM, Teixeira M, Filipe M, Resende TP et al. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res Ther [Internet]. 2014;5(1):5. Available from: https:\/\/doi.org\/10.1186\/scrt394","DOI":"10.1186\/scrt394"},{"key":"4316_CR22","doi-asserted-by":"publisher","unstructured":"L\u00f3pez Y, Lutjemeier B, Seshareddy K, Trevino EM, Hageman KS, Musch TI et al. Wharton\u2019s jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report. Curr Stem Cell Res Ther [Internet]. 2013;8(1):46\u201359. Available from: https:\/\/doi.org\/10.2174\/1574888x11308010007","DOI":"10.2174\/1574888x11308010007"},{"key":"4316_CR23","doi-asserted-by":"publisher","unstructured":"Balbi C, Bollini S. Fetal and perinatal stem cells in cardiac regeneration: Moving forward to the paracrine era. Placenta [Internet]. 2017;59:96\u2013106. Available from: https:\/\/doi.org\/10.1016\/j.placenta.2017.04.008","DOI":"10.1016\/j.placenta.2017.04.008"},{"key":"4316_CR24","unstructured":"Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica [Internet]. 2001;86(10):1099\u2013100. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11602418"},{"key":"4316_CR25","doi-asserted-by":"publisher","unstructured":"Musina RA, Bekchanova ES, Belyavskii AV, Grinenko TS, Sukhikh GT. Umbilical cord blood mesenchymal stem cells. Bull Exp Biol Med [Internet]. 2007;143(1):127\u201331. Available from: https:\/\/doi.org\/10.1007\/s10517-007-0032-z","DOI":"10.1007\/s10517-007-0032-z"},{"key":"4316_CR26","doi-asserted-by":"publisher","unstructured":"Fong C-Y, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton\u2019s jelly stem cells. Reprod Biomed Online [Internet]. 2010;21(3):391\u2013401. Available from: https:\/\/doi.org\/10.1016\/j.rbmo.2010.04.010","DOI":"10.1016\/j.rbmo.2010.04.010"},{"key":"4316_CR27","doi-asserted-by":"publisher","unstructured":"Wu Y, Li J, Feng K, Tan A, Gao Y, Chen W et al. N-CADHERIN+\/CD168- subpopulation determines therapeutic variations of UC-MSCs for cardiac repair after myocardial infarction. Stem Cell Res Ther [Internet]. 2024;15(1):423. Available from: https:\/\/doi.org\/10.1186\/s13287-024-04032-4","DOI":"10.1186\/s13287-024-04032-4"},{"key":"4316_CR28","doi-asserted-by":"publisher","unstructured":"Zhao L, Liu X, Zhang Y, Liang X, Ding Y, Xu Y et al. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction. Exp Cell Res [Internet]. 2016;344(1):30\u20139. Available from: https:\/\/doi.org\/10.1016\/j.yexcr.2016.03.024","DOI":"10.1016\/j.yexcr.2016.03.024"},{"key":"4316_CR29","doi-asserted-by":"publisher","unstructured":"Piao L, Huang Z, Inoue A, Kuzuya M, Cheng XW. Human umbilical cord-derived mesenchymal stromal cells ameliorate aging-associated skeletal muscle atrophy and dysfunction by modulating apoptosis and mitochondrial damage in SAMP10 mice. Stem Cell Res Ther [Internet]. 2022;13(1):226. Available from: https:\/\/doi.org\/10.1186\/s13287-022-02895-z","DOI":"10.1186\/s13287-022-02895-z"},{"key":"4316_CR30","doi-asserted-by":"publisher","unstructured":"Oommen S, Yamada S, Cantero Peral S, Campbell KA, Bruinsma ES, Terzic A et al. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Res Ther [Internet]. 2015;6(1). Available from: https:\/\/doi.org\/10.1186\/s13287-015-0044-y","DOI":"10.1186\/s13287-015-0044-y"},{"key":"4316_CR31","doi-asserted-by":"publisher","unstructured":"Di Maria MV, Goldberg DJ, Zak V, Hu C, Lubert AM, Dragulescu A et al. Impact of Udenafil on Echocardiographic Indices of Single Ventricle Size and Function in FUEL Study Participants. Circ Cardiovasc Imaging [Internet]. 2022;15(11):e013676. Available from: https:\/\/doi.org\/10.1161\/CIRCIMAGING.121.013676","DOI":"10.1161\/CIRCIMAGING.121.013676"},{"key":"4316_CR32","doi-asserted-by":"publisher","unstructured":"Yeh DD, Foster E. Is MRI the Preferred Method for Evaluating Right Ventricular Size and Function in Patients With Congenital Heart Disease? Circ Cardiovasc Imaging [Internet]. 2014;7(1):198\u2013205. Available from: https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000395","DOI":"10.1161\/CIRCIMAGING.113.000395"},{"key":"4316_CR33","doi-asserted-by":"publisher","unstructured":"Geva T. Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease? MRI is the preferred method for evaluating right ventricular size and function in patients with congenital heart disease. Circ Cardiovasc Imaging [Internet]. 2014;7(1):190\u20137. Available from: https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000553","DOI":"10.1161\/CIRCIMAGING.113.000553"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04316-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04316-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04316-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:41:37Z","timestamp":1746092497000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04316-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4316"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04316-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study titled \u201cPhase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood-Derived Mononuclear Cells during Stage II Surgical Repair of Hypoplastic Left Heart Syndrome (Auto Cell-II)\u201d was individually approved by the Institutional Review Boards (IRBs) at each participating site under protocol number CSP-4401 and IND 15343 on August 30, 2018.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have not used AI-generated work in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence"}}],"article-number":"215"}}